Nuvalent Inc (NUVL)
$92.96 -$0.27 (-0.29%) 4:37 PM 12/10/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$6.70B -
Day's Range
$91.53 - $94.21 -
Volume
282,777 -
52 Week Low / High
$61.80 - $113.51 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
NUVL's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 8
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $75.43
- Target Price
Company News
-
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates — Sep 19th, 2024
It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology (“ESMO”) by several companies. Other updates were also in focus. Among these, shares of Gilead Sciences GILD and Nuvalent NUVL surged after the companies reporte...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$